Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

MicroRNAs01:22

MicroRNAs

3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
MicroRNAs01:22

MicroRNAs

20.9K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
20.9K
Experimental RNAi02:15

Experimental RNAi

6.5K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Saliva-Activated Nanohybrid Aggregates Are Rapid-Acting Agglutination Agents with Potent Anticaries Activity and Limited Toxicity.

ACS pharmacology & translational science·2025
Same author

3D Printed Hollow Microneedles for Dermal and Transdermal Drug Delivery: Design, Fabrication, Application, and Perspective.

Molecular pharmaceutics·2025
Same author

Assessment of antibiotic release and antibacterial efficacy from pendant glutathione hydrogels using ex vivo porcine skin.

Journal of controlled release : official journal of the Controlled Release Society·2023
Same author

Rational Design of Topical Semi-Solid Dosage Forms-How Far Are We?

Pharmaceutics·2023
Same author

Nasal residence time and rheological properties of a new bentonite-based thixotropic gel emulsion nasal spray - AM-301.

Drug development and industrial pharmacy·2023
Same author

Biophysical Characterization of Interactions between Serum Albumin and Block Copolymer Micelles.

ACS biomaterials science & engineering·2022

Related Experiment Video

Updated: Apr 27, 2026

A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA
06:53

A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA

Published on: December 26, 2015

12.3K

Arginine-rich, cell penetrating peptide-anti-microRNA complexes decrease glioblastoma migration potential.

Yu Zhang1, Melanie Köllmer1, Jason S Buhrman1

  • 1Department of Biopharmaceutical Sciences, University of Illinois, Chicago, IL 60612-7231, USA.

Peptides
|June 28, 2014
PubMed
Summary

Octaarginine peptide (R8) effectively delivers single-stranded anti-microRNAs (miRNAs) into cells, inhibiting glioblastoma cell migration. This novel delivery system shows promise for miRNA-based therapeutics by enabling gene regulation.

Keywords:
Anti-miRNAsCell penetrating peptideGlioblastomamiRNA-21miRNAs

More Related Videos

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

2.2K
Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

5.2K

Related Experiment Videos

Last Updated: Apr 27, 2026

A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA
06:53

A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA

Published on: December 26, 2015

12.3K
Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

2.2K
Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

5.2K

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Genetics

Background:

  • MicroRNAs (miRNAs) are crucial gene regulators involved in numerous human diseases.
  • Dysregulated miRNA expression necessitates effective delivery systems for therapeutic intervention.
  • Cell-penetrating peptides (CPPs) are explored for delivering nucleic acids, but their efficacy with anti-miRNAs is less understood.

Purpose of the Study:

  • To evaluate the R8 peptide as a delivery vehicle for single-stranded anti-miRNAs.
  • To assess the intracellular delivery efficiency and endosomal escape of anti-miRNA/R8 complexes.
  • To investigate the therapeutic potential of anti-miR-21/R8 complexes in glioblastoma.

Main Methods:

  • Complexation of single-stranded anti-miRNA with the R8 peptide.
  • Quantification of anti-miRNA/R8 complex association with cells.
  • Assessment of endosomal/lysosomal escape of delivered anti-miRNA.
  • Evaluation of downstream gene upregulation and glioblastoma cell migration inhibition.

Main Results:

  • The R8 peptide successfully condensed both siRNA and anti-miRNA.
  • Over 50% of cells showed association with anti-miRNA/R8 complexes, with 68% achieving endosomal escape.
  • Administration of anti-miR-21 using R8 peptide led to efficient gene upregulation.
  • Glioblastoma cell migration was reduced by 25% compared to controls.

Conclusions:

  • Octaarginine (R8) peptide is an effective carrier for intracellular delivery of single-stranded anti-miRNAs.
  • The anti-miR-21/R8 complex demonstrates functional miRNA modulation and inhibits glioblastoma cell migration.
  • This study establishes a foundation for using R8 as a carrier for anti-miRNA therapeutics.